These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3151140)

  • 1. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
    Uttley AH; Collins CH
    Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
    Eltringham IJ; Wilson SM; Drobniewski FA
    J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
    Joloba ML; Bajaksouzian S; Jacobs MR
    J Clin Microbiol; 2000 Oct; 38(10):3834-6. PubMed ID: 11015413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
    Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
    Esteban J; Ortiz A; Jiménez MS
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):856-7. PubMed ID: 16315010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of primary resistance to antitubercular drugs in Galicia].
    Alvarez D; Valle JM; Martino MV; Gordo P; Carreira J; Valdés L
    Arch Bronconeumol; 1994; 30(6):297-300. PubMed ID: 8087389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of tuberculosis. The Mitchell lecture 1979.
    Mitchison DA
    J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of radiation on microbiologic characteristics of M tuberculosis.
    Zack MB; Stottmeier K; Berg G; Kazemi H
    Chest; 1974 Sep; 66(3):240-3. PubMed ID: 4213816
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
    Trivedi SS; Desai SG
    Tubercle; 1988 Mar; 69(1):37-42. PubMed ID: 3140458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.